AAPL296.20+1.90 (+0.64%) ▲|ABBV233.53-1.23 (-0.52%) ▼|ABT90.79+0.26 (+0.29%) ▲|ACN130.05+3.04 (+2.39%) ▲|ADBE198.23+0.80 (+0.41%) ▲|AMAT578.46-7.42 (-1.27%) ▼|AMD510.40-9.45 (-1.82%) ▼|AMGN350.93+3.92 (+1.13%) ▲|AMT173.56-5.82 (-3.24%) ▼|AMZN238.70+4.59 (+1.96%) ▲|AVGO381.01+0.86 (+0.23%) ▲|AXP342.16+4.38 (+1.30%) ▲|BA220.46+3.75 (+1.73%) ▲|BAC57.70-0.22 (-0.37%) ▼|BKNG183.73+14.79 (+8.75%) ▲|BLK985.25-30.09 (-2.96%) ▼|BMY54.95-0.58 (-1.04%) ▼|BNY144.51-2.79 (-1.89%) ▼|BRK-B494.98+2.17 (+0.44%) ▲|C143.93-1.04 (-0.72%) ▼|CAT983.70-0.55 (-0.06%) ▼|CL92.35+0.92 (+1.01%) ▲|CMCSA22.63-0.18 (-0.77%) ▼|COF201.87+4.06 (+2.05%) ▲|COP106.97-3.00 (-2.73%) ▼|COST958.53+0.85 (+0.09%) ▲|CRM153.85+0.43 (+0.28%) ▲|CSCO119.94-1.21 (-1.00%) ▼|CVS101.00-0.57 (-0.56%) ▼|CVX171.61-4.37 (-2.48%) ▼|DE605.26+13.32 (+2.25%) ▲|DHR187.83+8.86 (+4.95%) ▲|DIS101.98-1.55 (-1.50%) ▼|DUK125.18+0.13 (+0.10%) ▲|EMR141.51-1.63 (-1.14%) ▼|FDX311.99-5.26 (-1.66%) ▼|GD345.41-4.93 (-1.41%) ▼|GE366.40+9.93 (+2.79%) ▲|GEV1,055.04+20.06 (+1.94%) ▲|GILD125.42+0.37 (+0.30%) ▲|GM79.64+0.69 (+0.87%) ▲|GOOG348.60+2.52 (+0.73%) ▲|GOOGL349.43+3.34 (+0.97%) ▲|GS1,078.79-15.65 (-1.43%) ▼|HD339.84+15.39 (+4.74%) ▲|HON227.37+5.00 (+2.25%) ▲|IBM263.38-1.57 (-0.59%) ▼|INTC130.19-2.09 (-1.58%) ▼|INTU266.86+8.81 (+3.41%) ▲|ISRG402.25-0.94 (-0.23%) ▼|JNJ239.28+0.20 (+0.08%) ▲|JPM332.72-1.43 (-0.43%) ▼|KO80.74+0.43 (+0.54%) ▲|LIN516.86+4.60 (+0.90%) ▲|LLY1,105.73-1.35 (-0.12%) ▼|LMT493.93-9.75 (-1.93%) ▼|LOW220.48+6.94 (+3.25%) ▲|LRCX366.00-5.33 (-1.44%) ▼|MA494.10+6.03 (+1.23%) ▲|MCD274.02+2.36 (+0.87%) ▲|MDLZ62.18+1.12 (+1.83%) ▲|MDT80.42-0.21 (-0.26%) ▼|META556.97-5.24 (-0.93%) ▼|MMM166.52+4.68 (+2.89%) ▲|MO71.72+0.11 (+0.15%) ▲|MRK120.15+0.55 (+0.46%) ▲|MS220.90-5.13 (-2.27%) ▼|MSFT370.86-3.08 (-0.82%) ▼|MU1,021.90-29.87 (-2.84%) ▼|NEE86.72+0.29 (+0.34%) ▲|NFLX72.04-0.78 (-1.07%) ▼|NKE41.98-0.41 (-0.96%) ▼|NOW93.70-2.25 (-2.34%) ▼|NVDA198.06-1.94 (-0.97%) ▼|ORCL156.15-9.02 (-5.46%) ▼|PEP141.95-0.11 (-0.07%) ▼|PFE24.00-0.73 (-2.93%) ▼|PG152.15+1.29 (+0.86%) ▲|PLTR112.49-4.21 (-3.61%) ▼|PM177.04-1.65 (-0.92%) ▼|QCOM196.30-7.83 (-3.84%) ▼|RTX185.28-1.11 (-0.60%) ▼|SBUX103.44+2.39 (+2.36%) ▲|SCHW91.65-1.52 (-1.63%) ▼|SO94.76-0.17 (-0.18%) ▼|SPG219.68+2.94 (+1.36%) ▲|T22.40-0.42 (-1.82%) ▼|TMO488.33+18.98 (+4.04%) ▲|TMUS182.32-2.26 (-1.22%) ▼|TSLA375.31-6.30 (-1.65%) ▼|TXN302.98-1.39 (-0.46%) ▼|UBER73.52+3.85 (+5.53%) ▲|UNH404.24-5.02 (-1.23%) ▼|UNP259.31+0.70 (+0.27%) ▲|UPS104.87-0.96 (-0.91%) ▼|USB60.11+0.06 (+0.10%) ▲|V331.76+3.28 (+1.00%) ▲|VZ45.55-1.19 (-2.54%) ▼|WFC84.11-0.02 (-0.02%) ▼|WMT119.19-0.24 (-0.20%) ▼|XOM136.13-3.60 (-2.58%) ▼|AAPL296.20+1.90 (+0.64%) ▲|ABBV233.53-1.23 (-0.52%) ▼|ABT90.79+0.26 (+0.29%) ▲|ACN130.05+3.04 (+2.39%) ▲|ADBE198.23+0.80 (+0.41%) ▲|AMAT578.46-7.42 (-1.27%) ▼|AMD510.40-9.45 (-1.82%) ▼|AMGN350.93+3.92 (+1.13%) ▲|AMT173.56-5.82 (-3.24%) ▼|AMZN238.70+4.59 (+1.96%) ▲|AVGO381.01+0.86 (+0.23%) ▲|AXP342.16+4.38 (+1.30%) ▲|BA220.46+3.75 (+1.73%) ▲|BAC57.70-0.22 (-0.37%) ▼|BKNG183.73+14.79 (+8.75%) ▲|BLK985.25-30.09 (-2.96%) ▼|BMY54.95-0.58 (-1.04%) ▼|BNY144.51-2.79 (-1.89%) ▼|BRK-B494.98+2.17 (+0.44%) ▲|C143.93-1.04 (-0.72%) ▼|CAT983.70-0.55 (-0.06%) ▼|CL92.35+0.92 (+1.01%) ▲|CMCSA22.63-0.18 (-0.77%) ▼|COF201.87+4.06 (+2.05%) ▲|COP106.97-3.00 (-2.73%) ▼|COST958.53+0.85 (+0.09%) ▲|CRM153.85+0.43 (+0.28%) ▲|CSCO119.94-1.21 (-1.00%) ▼|CVS101.00-0.57 (-0.56%) ▼|CVX171.61-4.37 (-2.48%) ▼|DE605.26+13.32 (+2.25%) ▲|DHR187.83+8.86 (+4.95%) ▲|DIS101.98-1.55 (-1.50%) ▼|DUK125.18+0.13 (+0.10%) ▲|EMR141.51-1.63 (-1.14%) ▼|FDX311.99-5.26 (-1.66%) ▼|GD345.41-4.93 (-1.41%) ▼|GE366.40+9.93 (+2.79%) ▲|GEV1,055.04+20.06 (+1.94%) ▲|GILD125.42+0.37 (+0.30%) ▲|GM79.64+0.69 (+0.87%) ▲|GOOG348.60+2.52 (+0.73%) ▲|GOOGL349.43+3.34 (+0.97%) ▲|GS1,078.79-15.65 (-1.43%) ▼|HD339.84+15.39 (+4.74%) ▲|HON227.37+5.00 (+2.25%) ▲|IBM263.38-1.57 (-0.59%) ▼|INTC130.19-2.09 (-1.58%) ▼|INTU266.86+8.81 (+3.41%) ▲|ISRG402.25-0.94 (-0.23%) ▼|JNJ239.28+0.20 (+0.08%) ▲|JPM332.72-1.43 (-0.43%) ▼|KO80.74+0.43 (+0.54%) ▲|LIN516.86+4.60 (+0.90%) ▲|LLY1,105.73-1.35 (-0.12%) ▼|LMT493.93-9.75 (-1.93%) ▼|LOW220.48+6.94 (+3.25%) ▲|LRCX366.00-5.33 (-1.44%) ▼|MA494.10+6.03 (+1.23%) ▲|MCD274.02+2.36 (+0.87%) ▲|MDLZ62.18+1.12 (+1.83%) ▲|MDT80.42-0.21 (-0.26%) ▼|META556.97-5.24 (-0.93%) ▼|MMM166.52+4.68 (+2.89%) ▲|MO71.72+0.11 (+0.15%) ▲|MRK120.15+0.55 (+0.46%) ▲|MS220.90-5.13 (-2.27%) ▼|MSFT370.86-3.08 (-0.82%) ▼|MU1,021.90-29.87 (-2.84%) ▼|NEE86.72+0.29 (+0.34%) ▲|NFLX72.04-0.78 (-1.07%) ▼|NKE41.98-0.41 (-0.96%) ▼|NOW93.70-2.25 (-2.34%) ▼|NVDA198.06-1.94 (-0.97%) ▼|ORCL156.15-9.02 (-5.46%) ▼|PEP141.95-0.11 (-0.07%) ▼|PFE24.00-0.73 (-2.93%) ▼|PG152.15+1.29 (+0.86%) ▲|PLTR112.49-4.21 (-3.61%) ▼|PM177.04-1.65 (-0.92%) ▼|QCOM196.30-7.83 (-3.84%) ▼|RTX185.28-1.11 (-0.60%) ▼|SBUX103.44+2.39 (+2.36%) ▲|SCHW91.65-1.52 (-1.63%) ▼|SO94.76-0.17 (-0.18%) ▼|SPG219.68+2.94 (+1.36%) ▲|T22.40-0.42 (-1.82%) ▼|TMO488.33+18.98 (+4.04%) ▲|TMUS182.32-2.26 (-1.22%) ▼|TSLA375.31-6.30 (-1.65%) ▼|TXN302.98-1.39 (-0.46%) ▼|UBER73.52+3.85 (+5.53%) ▲|UNH404.24-5.02 (-1.23%) ▼|UNP259.31+0.70 (+0.27%) ▲|UPS104.87-0.96 (-0.91%) ▼|USB60.11+0.06 (+0.10%) ▲|V331.76+3.28 (+1.00%) ▲|VZ45.55-1.19 (-2.54%) ▼|WFC84.11-0.02 (-0.02%) ▼|WMT119.19-0.24 (-0.20%) ▼|XOM136.13-3.60 (-2.58%) ▼|
27.5 C
New York
Wednesday, June 24, 2026

Tag: lawyers

newssourceFORcompanyinformationcontent1marketreleases

INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Sarepta Therapeutics, Inc. (SRPT) Investors with Substantial Losses Have Opportunity to Lead the Sarepta...

SAN DIEGO, June 30, 2025 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Sarepta Therapeutics, Inc. (NASDAQ: SRPT) securities between June 22, 2023 and June 24, 2025, both dates inclusive (the “Class Period”), have until August 25, 2025 to seek appointment as lead plaintiff of the Sarepta class action lawsuit. Captioned Dolgicer v. Sarepta Therapeutics, Inc., No. 25-cv-05317 (S.D.N.Y.), the Sarepta class action lawsuit charges Sarepta and certain of Sarepta’s top executives with violations of the Securities Exchange Act of 1934.

INVESTOR DEADLINE: Robbins Geller Announces that Organon & Co. (OGN) Investors with Substantial Losses Have Opportunity to Lead Securities Class Action Lawsuit

SAN DIEGO, June 27, 2025 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & Dowd LLP announces that the Organon class action lawsuit – captioned Hauser v. Organon & Co., No. 25-cv-05322 (D.N.J.) – seeks to represent purchasers or acquirers of Organon & Co. (NYSE: OGN) securities and charges Organon as well as certain of Organon’s top executives with violations of the Securities Exchange Act of 1934.

GoHealth, Inc. Investor News: If You Have Suffered Losses in GoHealth, Inc. (NASDAQ: GOCO), You Are Encouraged to Contact The Rosen Law Firm About...

NEW YORK, June 27, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of GoHealth, Inc. (NASDAQ: GOCO) resulting from allegations that GoHealth may have issued materially misleading business information to the investing public.

EGBN Investor News: If You Have Suffered Losses in Eagle Bancorp, Inc. (NASDAQ: EGBN), You Are Encouraged to Contact The Rosen Law Firm About...

NEW YORK, June 27, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Eagle Bancorp, Inc. (NASDAQ: EGBN) resulting from allegations that Eagle Bancorp may have issued materially misleading business information to the investing public.

ROSEN, LEADING TRIAL ATTORNEYS, Encourages PepGen Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – PEPG

NEW YORK, June 27, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of PepGen Inc. (NASDAQ: PEPG) between March 7, 2024 and March 3, 2025, both dates inclusive (the “Class Period”), of the important August 8, 2025 lead plaintiff deadline.

MONDAY INVESTOR DEADLINE: Open Lending Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit – LPRO

SAN DIEGO, June 26, 2025 /PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Open Lending...

מועד אחרון לתביעה נגד CODI: רוזן, יועץ למשקיעים גלובלי, מעודד את המשקיעים ב- Compass Diversified Holdings להשיג ייעוץ לפני המועד האחרון החשוב של 8...

ניו יורק, June 26, 2025 (GLOBE NEWSWIRE) --

מדוע: משרד רוזן עורכי דין (Rosen Law Firm), משרד עורכי דין בינלאומי העוסק בזכויות משקיעים, מזכיר לרוכשים את ניירות הערך של Compass Diversified Holdings (NYSE: CODI) בין התאריכים 1 במאי 2024 עד 7 במאי 2025, שני התאריכים כוללים ("התקופה הייצוגית"), את המועד האחרון החשוב של 8 ביולי 2025 להגשת תביעה ייצוגית בניירות ערך שהוגשה לראשונה על ידי המשרד.

מועד אחרון לתביעה נגד LPRO: רוזן, יועץ למשקיעים מוביל, מעודד משקיעים ב- Open Lending Corporation להשיג ייעוץ לפני המועד האחרון החשוב של 30 ביוני...

ניו יורק, June 26, 2025 (GLOBE NEWSWIRE) --

מדוע: משרד רוזן עורכי דין (Rosen Law Firm), משרד עורכי דין בינלאומי העוסק בזכויות משקיעים, מזכיר לרוכשים את ניירות הערך של Open Lending Corporation (נאסד"ק: LPRO) בין התאריכים 24 בפברואר 2022 עד 31 במרץ 2025, שני התאריכים כוללים ("התקופה הייצוגית"), את המועד האחרון החשוב של 30 ביוני 2025 להגשת תביעה ייצוגית בניירות ערך.

HIMS INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Hims & Hers Health, Inc. Investors with Substantial Losses Have Opportunity to Lead...

SAN DIEGO, June 25, 2025 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Hims & Hers Health, Inc. (NYSE: HIMS) securities between April 29, 2025 and June 23, 2025, inclusive (the “Class Period”), have until August 25, 2025 to seek appointment as lead plaintiff of the Hims & Hers class action lawsuit. Captioned Sookdeo v. Hims & Hers Health, Inc., No. 25-cv-05315 (N.D. Cal.), the Hims & Hers class action lawsuit charges Hims & Hers and certain of Hims & Hers’ top executives with violations of the Securities Exchange Act of 1934. A subsequently filed complaint is captioned Yaghsizian v. Hims & Hers Health, Inc., No. 25-cv-05321 (N.D. Cal.).

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Organon & Co. Investors to Secure Counsel Before Important Deadline in Securities Class Action – OGN

NEW YORK, June 25, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Organon & Co. (NYSE: OGN) between October 31, 2024 and April 30, 2025, both dates inclusive (the “Class Period”), of the important July 22, 2025 lead plaintiff deadline.

ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Rocket Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – RCKT

NEW YORK, June 25, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) between February 27, 2025 and May 26, 2025, both dates inclusive (the “Class Period”), of the important August 11, 2025 lead plaintiff deadline.

Anthropic Wins a Battle, But the War Ain’t Over

Anthropic just scored a win in the legal jungle that is AI and copyright. A court ruled it was fair game for them to...

ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Reckitt Benckiser Group PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action –...

NEW YORK, June 24, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of American Depositary Shares (“ADSs”) of Reckitt Benckiser Group PLC (OTC: RBGLY) between January 13, 2021 through July 28, 2024, both dates inclusive (the “Class Period”), of the important August 4, 2025 lead plaintiff deadline.

Shiner Law Group Launches Dedicated Legal Department for Uber and Lyft Rideshare Accident Cases

BOCA RATON, Fla., June 24, 2025 /PRNewswire/ -- Shiner Law Group, a leading Florida personal injury law firm, is proud to announce the creation...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsLawyers

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers